The aim of this study was to examine the effect of treatment type on anxiety in patients with cervical cancer. Subjects and methods:
Introduction
In 2005, there were over 500,000 new cases of cervical cancer, and it is estimated that most of the over one million women worldwide who currently have cervical cancer have not been diagnosed. According to the World Health Organization (WHO), cervical cancer is the second most common type of cancer among women and was responsible for over 260,000 deaths in 2005, nearly 95% of which occurred in developing countries [1] . Serbia has the highest incidence of cervical cancer compared to other republics of the former Yugoslavia and one of the largest among the countries of Southeast Europe [2] . In recent years, the incidence peak for cervical cancer has shifted towards younger age groups.
Cervical cancer treatment depends upon disease stage; possibilities include surgery, radiotherapy, chemotherapy, or hemoradiation. The advantage of surgical treatment is that it enables proper surgical-pathological staging of the disease, avoids ovarian failure (transposition); preserves the functions of vagina, and ensures correct "follow up". After surgery, if there are no obvious risk factors (adenocarcinoma, small differentiated tumors, involvement of lymph nodes, presence of lymphovascular invasion, presence of residual tumor, bulky form of cancer), only tertial prevention is applied and no adjuvant therapy is necessary [3] .
Anxiety is a frequent response to the series of cancer diagnosis, treatment, remission, and relapse [4] . The prevalence of a high level of anxiety in cancer patients varies from 10% to 50% [5] . Reducing the patient's anxiety level is important because anxiety may lead to emotional distress and functional disturbances [6, 7] .
Receiving a diagnosis of gynecologic cancer generates various psychosocial and emotional responses: anxiety, denial, passivity, annihilation of long-term plans and personal responsibilities, worries of the near future and death. In gynecologic cancer, sexuality and representation of femininity alterations can seriously complicate the psychic representation of disease and impair family life [5] .
Inspired by the extensive literature on this subject, as well as a series of contradictory data and a number of methodological flaws of previous studies, we undertook this research with the goal of observing the influence of surgery and radiotherapy on the degree of anxiety before and after surgery, and to determine factors significantly related to a poor outcome after the psychophysiological outcome after the operation.
The aim of the present study was to test the difference in the severity and risk factors for anxiety in female patients with cervical cancer: Group 1 underwent surgery combined with radiotherapy and chemotherapy, and Group 2 underwent only radiotherapy and chemotherapy. Inclusion criteria were: age 30-60 years, having completed at least secondary education, married, the existence of malignant lesions of the cervix, absence of serious somatic disease, absence of serious psychiatric disorders treated in hospital in the personal history. The control group had the same characteristics as group I and group II except for existence of malignant lesions of the cervix. Data were collected at recruitment (baseline) and after 3 and 6 months follow-up.
Methods
To evaluate anxiety level, the Hamilton Anxiety Scale (HAM-A), a rating scale developed to quantify the severity of anxiety symptomatology, was used [8] . It consists of 14 items defined by a series of symptoms; each item is rated on a 5-point scale ranging from 0 (not present) to 4 (severe). Study subjects were divided into three groups according to the total score on Hamilton scale: mild anxiety, less than 17; moderate anxiety, 18-24; severe anxiety, 25-30.
The study was approved by the local research ethics committee, and informed consent was obtained from all individuals enrolled in the study.
Statistical analysis Calculations were performed using SPSS program version 10.0 (Statistical Package for Social Sciences 10.0) and the StatCalc program of the EPI-INFO software package version 6. The following statistical parameters were extracted: arithmetic mean (X), standard deviation (SD), structure index (%,) and 95% confidence interval (95% IP).
Assessment of significance of differences was determined by Student's t test, Mann-Whitney U test, analysis of variance (ANOVA), Dunnet post hoc test, MantelHaenszel Chi-square test, Fischer's exact probability test of null hypothesis (Fisher exact test), Friedman test and logistic regression analysis. Approximate values of relative risk (odds ratio, OR) and 95% confidence intervals were calculated. Assessment of statistical significance of OR values was performed by calculating Wald values. Factors for which the univariant logistic regression showed to significantly affect the change of categories depending on these variables were included in the multivariate regression models. By applying the step by step backwards method (Backward: Wald) out of multivariate models, all those factors whose impact was not statistically significant were excluded.
As the threshold for statistical significance, level in error estimates less than 5% (p <0.05) was used.
Results
The average age among patients with cervical cancer was 48.87±5.28 in group I, 47±5.80 group II, and 46±5.39 among controls. There was no significant age difference between the groups.
The average value of HAM-A in patients who were treated surgically (group I) was 18.47±4.3 before therapy and then decreased significantly to 17.17±3.90 and 15.23±4.53, three and six months after surgery, respectively (Table 1 ). In the group of patients who were treated by radiotherapy (group II), the average value of the HAM-A was 15.07±5.15 before therapy and also decreased significantly to 13.57±5.75 after three months and 11.57±5.64 after six months. In the control group, the average value of HAM-A was 5.00±4.86. At baseline, the HAM-A values in patients treated surgically were significantly higher than those in patients treated by radiotherapy (ANOVA and Dunnet test: p=0.023) and also than those in patients in the control group (ANOVA and Dunnet test: p<0.001). Patients who were treated by radiotherapy had significantly higher average HAM-A values than the correspondents from the control group (ANOVA and Dunnet test: p<0.001). In retesting after three and six months, the value of surgically treated patients remained significantly higher compared with those of women who were treated by radiotherapy (Mann-Whitney U test: p=0.006 and p=0.003, respectively) ( Table 2) .
Before start of therapy, mild anxiety was found in 36.7% of patients who were treated surgically, but in 63.3% of patients treated with radiotherapy ( Table 4 . Unadjusted effects of categorical predictor variables on anxiety levels obtained from logistic regressions surgical therapy, the risk of moderate or severe anxiety was 62 times higher than in those in the control group (OR=62.22, p <0.001); however, in patients before radiotherapy, the risk was 16 times higher than that in women in the control group (OR=16.03, p=0.01).
In patients who had an infection, risk of anxiety was 3 times lower than in those without infection (OR=0:30, p=0.03) ( Table 5) .
Pain significantly increased risk of moderate or severe anxiety (OR=4.25, p=0.002 ). Irregular menstrual bleeding (OR=2:43, p=0.052) affected the increase of risk (Table 6 ). Openness produced reduction of risk (OR=0:36; 95% IP: 0.12-1.07), but the statistical significance of these claims is based on the probability error estimates of less than 0.1 (10%).
Time to answering physician and the stage of the disease have not been confirmed as factors that significantly influence the occurrence of anxiety before the start of therapy.
In the second and third test, patients after surgery had a significantly higher risk for the presence of moderate or severe anxiety than patients after radiotherapy, and patients who were talking openly about their disease had lower risk for the presence of moderate or severe anxiety.
Discussion
Genital organs, along with secondary sex characteristics, are determinants of the biological sex of the individual, and are the basis upon which sexual identity is formed during development. Hence, each disorder, trauma, or surgery on genitals can result in significant disturbance of gender identity, crisis reactions with anxiety-depressive content, even in psychotic reactions.
It has been suggested that younger patients are at greater risk of psychiatric disorders after hysterectomy [9] . Gath & Cooper did not confirm this hypothesis, as they found no correlation between psychiatric disorders after surgical hysterectomy and age below 35 years [10] . In our study, age of the groups ranged from 30 to 59 years. Distribution by age groups was equal. No association was found between age and higher anxiety scores.
The subjects in our study were not treated by a psychiatrist, either as inpatients or outpatients. Some had past medical history with data on rare anxiolytics used in small doses and for short time intervals. Most patients explain any anxiety or depressive symptoms in the preoperative and postoperative period by a current social crisis, which has broad implications for almost all spheres of individual functioning. Anxiety and depression in Korean cervical cancer survivors (CCSs) were commonly associated with financial difficulty, poor body image, sexual inactivity, and low existential wellbeing [11] .
The importance of preoperative anxiety, which is correlated with expected postoperative anxiety, recovery speed, and the emergence of pain after surgery should be recalled [12] . In our study, high scores for anxiety on the HAM-A in the group of persons who underwent hysterectomy were noted preoperatively. This is consistent with data from literature which, on one hand, show that fear is the most intense on hospital admission because of the change from the everyday to the hospital environment itself, particularly in those patients who have never been hospitalized or have not undergone surgery. Fear is most pronounced just before the surgery, awaiting the entry into the operating room. Scores for anxiety in both groups (patients who were surgically treated, and those treated by radiotherapy) declined three and six months after treatment. This level of anxiety could be explained by the fact that hysterectomy initiates a number of penetration fears related to injury, destruction, being in Table 6 . Correlation values of symptoms in three stages of the disease a dependent position, helplessness, death, separation fear related to the abandonment of significant others, fear of losing sphincter control, as well as specific fears related to impact of surgery on sexual functioning. Radiotherapy leads to increased anxiety less than radical hysterectomy and refers to the uncertainty and tension that is felt before facing a difficult situation, and declines after the radiotherapy. Pain and irregular menstrual bleeding lead to increased anxiety, but it is significantly lower in those patients who are willing to talk openly about their illness. High scores for anxiety in the group who underwent radiotherapy were also observed, but with lower values than those in patients treated surgically. Radiation causes difficulties in the psychological sense, through fear of technology: whether the treatment will be painful, fear of something new and unknown, fear that there will be more harm than good resulting from constant media suggestions that the radiation is harmful, fear of irradiating people with whom they come into contact, what if the machine breaks down, and so on. Also, there is fear because the tumor is not removed during the process of radiation and remains in the body [13, 14] . In the surgical patients, prominent anxiety is present before surgery because of fear of surgery and failure in organs important for sexuality. Especially for younger women, surgery represents a loss of fertility, youth, desirability and sexual attraction, explaining the elevated levels of anxiety in the third tests [15] . In a critical review of patient-related quality of life (QoL) studies in long-term survivors of CCSs, QoL in cervical cancer survivors was found to be reduced compared with the general female population following radiotherapy, but less so following surgery and in earlier stages of cervical cancer [16] . Several cervical cancer therapies have shown response rate improvements in combination with cisplatin, including topotecan and paclitaxel. The topotecan/cisplatin combination significantly increases overall survival rates without reducing patient QoL. In view of the increased potential for toxicity when chemotherapeutic agents are combined, future clinical trials of combination therapy should include assessment of patient QoL [17] .
Conclusion
During the whole monitoring time, anxiety was more pronounced in the group that underwent surgery than in the group that underwent radiotherapy, but the intensity of anxiety gradually decreased in both groups. In this study, pain and irregular menstrual bleeding were the most important risk factors for the development of anxiety in patients with cervical cancer. Routine assessment should be introduced in clinical practice for the detection and monitoring of anxiety in all patients with cervical cancer, and a psychiatrist should be included in the multidisciplinary team for their treatment.
